These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Variant Creutzfeldt-Jakob disease: risk of transmission by blood transfusion and blood therapies. Ironside JW. Haemophilia; 2006 Mar; 12 Suppl 1():8-15; discussion 26-8. PubMed ID: 16445812 [Abstract] [Full Text] [Related]
5. Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study. Hewitt PE, Llewelyn CA, Mackenzie J, Will RG. Vox Sang; 2006 Oct; 91(3):221-30. PubMed ID: 16958834 [Abstract] [Full Text] [Related]
7. Creutzfeldt-Jakob disease and haemophilia: assessment of risk. Evatt B. Haemophilia; 2000 Jul; 6 Suppl 1():94-9. PubMed ID: 10982274 [No Abstract] [Full Text] [Related]
8. Insights into the management of emerging infections: regulating variant Creutzfeldt-Jakob disease transfusion risk in the UK and the US. Ponte ML. PLoS Med; 2006 Oct; 3(10):e342. PubMed ID: 17076547 [Abstract] [Full Text] [Related]
13. An update on the assessment and management of the risk of transmission of variant Creutzfeldt-Jakob disease by blood and plasma products. Turner ML, Ludlam CA. Br J Haematol; 2009 Jan; 144(1):14-23. PubMed ID: 18950452 [Abstract] [Full Text] [Related]